logo
Arena Group Posts Third Consecutive Profitable Quarter in Q1 2025 with $4.0 Million in Net Income

Arena Group Posts Third Consecutive Profitable Quarter in Q1 2025 with $4.0 Million in Net Income

Business Wire18-05-2025
NEW YORK--(BUSINESS WIRE)--The Arena Group Holdings, Inc. (NYSE American: AREN) ('Arena'), a technology platform and media company home to hundreds of media brands, including TheStreet, Parade, Men's Journal, Athlon Sports, Surfer, Powder and more today announced financial results for the three months ending March 31, 2025 ('Q1 2025').
Financial Highlights for Q1 2025:
Quarterly revenue was $31.8 million compared to $28.9 million for Q1 2024.
Net income was $4.0 million, or $0.08 per diluted share for Q1 2025, compared to a net loss of $103 million, including a $91 million loss from discontinued operations, or $3.91 per diluted share in Q1 2024.
Income from continuing operations was $4.0 million in Q1 2025 compared to a loss from continuing operations of $12.7 million in Q1 2024, nearly a $17 million swing.
Adjusted EBITDA for Q1 2025 was $9.7 million compared to negative Adjusted EBITDA of $848 thousand for Q1 2024.
Financial Guidance for Q2 2025:
Expected revenue of approximately $40-$45 million.
Income from continuing operations of approximately $9 - $11 million.
'In Q1 2025, we expanded our brand-building activities and competitive publishing model originally pioneered with Athlon Sports to more of our brands, and the results have exceeded expectations,' said Paul Edmondson, CEO of The Arena Group. 'Our entrepreneurial publishers have brought extraordinary energy and commitment to each brand. By aligning incentives with audience engagement, we've unlocked significant growth in our users, distribution and revenue. This performance reaffirms the power of our model.'
'Our goal is to leverage this new approach across our entire platform — driving traffic, higher CPMs, and increased revenue, while maintaining expense discipline to sustain profitability,' Edmondson added. 'With these results, we believe we are well-positioned to maintain profitability throughout 2025.'
Operational highlights:
Athlon Sports: Audience traffic continues to grow significantly, with traffic increasing over 500% in Q1 2025 vs. Q1 2024. Our commitment to building a diversified revenue stream for Athlon continues to pay off with syndication and commerce revenue growing 730% year-over-year vs Q1 2024.
Men's Journal 's traffic increased 282% over the previous month to 33.1 million page views in March 2025, the first month of competitive publishing.
TheStreet: The financial brand reached record traffic levels in March 2025, delivering 80 million page views, up 100% vs March 2024.
Parade: Digital traffic of Parade and Parade Pets also remained strong with more than 76 million monthly page views in Q1 2025 (up 2% vs Q4 2024).
Arena recently acquired the travel brand, TravelHost. This iconic publication was founded in the mid-1960s and was the first in-room hotel magazine. It now provides travelers with local insights in 30+ markets. Arena intends to fully update and modernize the site and the brand's offerings.
Video Message:
Paul Edmondson, The Arena Group's CEO, has posted a video reviewing Arena's quarterly results and business strategy. The video addresses questions previously submitted by investors and other interested parties. It has been shared across Arena's social media channels and is available HERE.
About The Arena Group
The Arena Group (NYSE American: AREN) is an innovative technology platform and media company with a proven cutting-edge playbook that transforms media brands. Our unified technology platform empowers creators and publishers with tools to publish and monetize their content, while also leveraging quality journalism of anchor brands like TheStreet, Parade, Men's Journal, Athlon Sports, Surfer, Powder and more to build their businesses. The company aggregates content across a diverse portfolio of brands, reaching over 100 million users monthly. Visit us at thearenagroup.net and discover how we are revolutionizing the world of digital media.
As of
(unaudited) December 31, 2024
($ in thousands, except share data)
Assets
Current assets:
Cash and cash equivalents
$
2,902
$
4,362
Accounts receivables, net
31,561
31,115
Prepayments and other current assets
4,682
4,757
Total current assets
39,145
40,234
Property and equipment, net
107
148
Operating lease right-of-use assets
2,260
2,340
Platform development, net
8,471
8,115
Acquired and other intangible assets, net
21,940
22,789
Other long term assets
147
151
Goodwill
42,575
42,575
Total assets
114,645
116,352
Liabilities, mezzanine equity and stockholders' deficiency
Current liabilities:
Accounts payable
3,615
4,844
Accrued expenses and other
10,802
10,990
Unearned revenue
5,230
6,349
Subscription refund liability
662
430
Operating lease liability, current portion
97
254
Liquidating damages payable
3,305
3,230
Current liabilities from discontinued operations
96,056
96,159
Total current liabilities
119,767
122,256
Unearned revenue, net of current portion
193
403
Operating lease liability, net of current portion
2,182
1,964
Deferred tax liabilities
833
802
Simplify loan
7,151
10,651
Debt
110,467
110,436
Total liabilities
240,593
246,512
Mezzanine equity:
Series G redeemable and convertible preferred stock, $0.01 par value, $1,000 per share liquidation value and 1,800 shares designated; aggregate liquidation value: $168; Series G shares issued and outstanding: 168; common shares issuable upon conversion: 8,582 at December 31, 2024 and December 31, 2023
168
168
Total mezzanine equity
168
168
Stockholders' deficiency:
Common stock, $0.01 par value, authorized 1,000,000,000 shares; issued and outstanding: 47,556,267 and 23,836,706 shares at December 31, 2024 and December 31, 2023, respectively
475
475
Additional paid-in capital
348,752
348,560
Accumulated deficit
(475,343
)
(479,363
)
Total stockholders' deficiency
(126,116
)
(130,328
)
Total liabilities, mezzanine equity and stockholders' deficiency
$
114,645
$
116,352
Expand
THE ARENA GROUP HOLDINGS, INC. AND SUBSIDIARIES
Three Months Ended March 31,
2025
2024
($ in thousands, except share data)
Revenue
$
31,815
$
28,941
Cost of revenue (includes amortization of platform development and developed technology for 2024 and 2023 of $5,988 and $8,782, respectively)
16,146
20,008
Gross profit
15,669
8,933
Operating expenses
Selling and marketing
2,134
4,564
General and administrative
5,283
10,135
Depreciation and amortization
890
987
Loss on impairment of assets
-
1,198
Total operating expenses
8,307
16,884
Income (loss) from operations
7,362
(7,951
)
Other (expense) income
Change in valuation of contingent consideration
-
(313
)
Interest expense, net
(3,004
)
(4,339
)
Liquidated damages
(75
)
(76
)
Total other expense
(3,079
)
(4,728
)
Income (loss) before income taxes
4,283
(12,679
)
Income tax provision
(286
)
(41
)
Income (loss) from continuing operations
3,997
(12,720
)
Income (loss) from discontinued operations, net of tax
23
(90,638
)
Net income (loss)
$
4,020
$
(103,358
)
Basic and diluted net income (loss) per common share:
Continuing operations
$
0.08
$
(0.48
)
Discontinued operations
-
(3.43
)
Basic and diluted net income (loss) per common share
$
0.08
$
(3.91
)
Weighted average number of common shares outstanding
Basic
47,458,076
26,443,764
Expand
Use of Non-GAAP Financial Measures
We report our financial results in accordance with generally accepted accounting principles in the United States of America ('GAAP'); however, management believes that certain non-GAAP financial measures provide users of our financial information with useful supplemental information that enables a better comparison of our performance across periods. We believe Adjusted EBITDA provides visibility to the underlying continuing operating performance by excluding the impact of certain items that are noncash in nature or not related to our core business operations. We calculate Adjusted EBITDA as net income (loss) as adjusted for loss from discontinued operations, with additional adjustments for (i) interest expense (net), (ii) income taxes, (iii) depreciation and amortization, (iv) stock-based compensation, (v) change in valuation of contingent consideration, (vi) liquidated damages, (vii) loss on impairment of assets, (viii) loss on sale of assets; (ix) employee retention credit, (x) employee restructuring payments, and (xi) professional and vendor fees. Our non-GAAP measure may not be comparable to similarly titled measures used by other companies, have limitations as an analytical tool, and should not be considered in isolation, or as a substitute for analysis of our operating results as reported under GAAP. Additionally, we do not consider our non-GAAP measures as superior to, or a substitute for, the equivalent measures calculated and presented in accordance with GAAP. Some of the limitations are that our presentation of Adjusted EBITDA:
does not reflect interest expense and financing fees, or the cash required to service our debt, which reduces cash available to us;
does not reflect income tax provision or benefit, which is a noncash income or expense;
does not reflect depreciation and amortization expense and, although this is a noncash expense, the assets being depreciated may have to be replaced in the future, increasing our cash requirements;
does not reflect stock-based compensation and, therefore, does not include all of our compensation costs;
does not reflect the change in valuation of contingent consideration and, although this is a noncash income or expense, the change in the valuations each reporting period are not impacted by our actual business operations but is instead strongly tied to the change in the market value of our common stock;
does not reflect liquidated damages and, therefore, does not include future cash requirements if we repay the liquidated damages in cash instead of shares of our common stock (which the investor would need to agree to);
does not reflect any losses from the impairment of assets, which is a noncash operating expense;
does not reflect any losses from the sale of assets, which is a noncash operating expense
does not reflect the employee retention credits recorded by us for payroll related tax credits under the CARES Act;
does not reflect payments related to employee severance and employee restructuring changes for our former executives;
does not reflect the professional and vendor fees incurred by us for services provided by consultants, accountants, lawyers, and other vendors, which services were related to certain types of events that are not reflective of our business operations; and
may not reflect proper non direct cost allocations.
The following table presents a reconciliation of Adjusted EBITDA to net income (loss), which is the most directly comparable GAAP measure, for the periods indicated:
(1)
Interest expense is related to our capital structure and varies over time due to a variety of financing transactions. Interest expense includes $31 and $536 for amortization of debt discounts for the three months ended March 31, 2025 and 2024, respectively, as presented in our condensed consolidated statements of cash flows, which are noncash items. Investors should note that interest expense will recur in future periods.
(2)
Depreciation and amortization related to our developed technology and Platform is included within cost of revenues of $1,276 and $1,549 for the three months ended March 31, 2025 and 2024, respectively, and depreciation and amortization is included within operating expenses of $890 and $987 for the three months ended March 31, 2025 and 2024, respectively. We believe (i) the amount of depreciation and amortization expense in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired tangible and intangible assets. Investors should note that the use of tangible and intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation and should also note that such expense will recur in future periods.
(3)
Stock-based compensation represents noncash costs arise from the grant of stock-based awards to employees, consultants and directors. We believe that excluding the effect of stock-based compensation from Adjusted EBITDA assists management and investors in making period-to-period comparisons in our operating performance because (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations, and (ii) such expenses can vary significantly between periods as a result of the timing of grants of new stock-based awards, including grants in connection with acquisitions. Additionally, we believe that excluding stock-based compensation from Adjusted EBITDA assists management and investors in making meaningful comparisons between our operating performance and the operating performance of other companies that may use different forms of employee compensation or different valuation methodologies for their stock-based compensation. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods. Investors should also note that such expenses will recur in the future.
(4)
Change in fair value of contingent consideration represents the change in the put option on our common stock in connection with the Fexy Studios acquisition.
(5)
Liquidated damages (or interest expense related to accrued liquidated damages) represents amounts we owe to certain of our investors in private placements offerings conducted in fiscal years 2018 through 2020, pursuant to which we agreed to certain covenants in the respective securities purchase agreements and registration rights agreements, including the filing of resale registration statements and becoming current in our reporting obligations, which we were not able to timely meet.
(6)
Loss on impairment of assets represents certain assets that are no longer useful.
(7)
Employee restructuring payments represents severance payments to employees under employer restructuring arrangements and payments for the three months ended March 31, 2025 and 2024, respectively.
Expand
Forward-Looking Statements
This Press Release of The Arena Group Holdings, Inc. (the 'Company,' 'we,' 'our,' and 'us') contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). Forward-looking statements relate to future events or future performance and include, without limitation, statements concerning our business strategy, future revenues and income from continuing operations, cost reductions, market growth, capital requirements, product introductions, expansion plans and the adequacy of our funding and our ability to alleviate the conditions that raise substantial doubt about our ability to continue as a going concern (as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on April 15, 2025 (the '2024 10-K') and in our other SEC filings and publicly available documents). Other statements contained in this Press Release that are not historical facts are also forward-looking statements. We have tried, wherever possible, to identify forward-looking statements by terminology such as 'may,' 'will,' 'could,' 'should,' 'expects,' 'anticipates,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and other stylistic variants denoting forward-looking statements.
We caution investors that any forward-looking statements presented in this Press Release, or that we may make orally or in writing from time to time, are based on information currently available, as well as our beliefs and assumptions. The actual outcome related to forward-looking statements will be affected by known and unknown risks, trends, uncertainties, and factors that are beyond our control or ability to predict. Although we believe that our assumptions are reasonable, they are not guarantees of future performance, and some will inevitably prove to be incorrect. As a result, our actual future results can be expected to differ from our expectations, and those differences may be material. Accordingly, investors should use caution in relying on forward-looking statements, which are based only on known results and trends at the time they are made, to anticipate future results or trends. We detail other risks in our public filings with the Securities and Exchange Commission (the 'SEC'), including in Part I, Item 1A, Risk Factors, in the 2024 10-K and in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the 'Q1 10-Q'). The discussion in this Press Release should be read in conjunction with the consolidated financial statements and notes thereto included in Part II, Item 8 in the 2024 10-K and in the Q1 10-Q.
This Press Release and all subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We do not undertake any obligation to release publicly any revisions to our forward-looking statements to reflect events or circumstances after the date of this Press Release except as may be required by law.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

EON Resources Inc. Posts Updated Investor Deck and Q2 2025 Earnings Call Deck to the Company Website
EON Resources Inc. Posts Updated Investor Deck and Q2 2025 Earnings Call Deck to the Company Website

Associated Press

time10 hours ago

  • Associated Press

EON Resources Inc. Posts Updated Investor Deck and Q2 2025 Earnings Call Deck to the Company Website

HOUSTON, TX / ACCESS Newswire / August 19, 2025 / EON Resources Inc. (NYSE American:EONR) ('EON' or the 'Company') is independent upstream energy company with 20,000 leasehold acres comprised of two fields in the Permian Basin in southeast New Mexico. The fields have a total of 750 producing and injection wells producing over 1,000 barrels of oil per day. Today, the Company posted an updated investor deck and the second quarter of 2025 earnings call deck to the Company's website: About EON Resources Inc. EON is an independent upstream energy company focused on maximizing total returns to its shareholders through the development of onshore oil and natural gas properties in the United States. EON's long-term goal is to maximize total shareholder value from a diversified portfolio of long-life oil and natural gas properties built through acquisition and through selective development, production enhancement, and other exploitation efforts on its oil and natural gas properties. EON's Class A Common Stock trades on the NYSE American Stock Exchange (NYSE American: EONR) and the Company's public warrants trade on the NYSE American Stock Exchange (NYSE American: EONR WS). For more information on EON, please visit the Company's website: About the Grayburg-Jackson Oil Field Property LH Operating, LLC ('LHO'), a wholly owned subsidiary of EON, operates its holdings in New Mexico of oil and gas waterflood production comprising 13,700 contiguous leasehold acres, 342 producing wells and 207 injection wells situated on 20 federal and 3 state leases in the Grayburg-Jackson Oil Field. The Grayburg-Jackson Oil Field is located on the Northwest Shelf of the prolific Permian Basin in Eddy County, New Mexico. Leasehold rights of LHO include the Seven Rivers, Queen, Grayburg and San Andres intervals that range from as shallow as 1,500 feet to 4,000 feet in depth. The December 2024 reserve report from our third-party engineer, Haas and Cobb Petroleum Consultants, LLC ('Haas & Cobb' or 'Cobb'), reflects LHO to have proven reserves of approximately 14.0 million barrels of oil and 2.8 billion cubic feet of natural gas. The mapped original-oil-in-place ('OOIP') in the LHO leasehold is approximately 876 million barrels of oil in the Grayburg and San Andres intervals and 80 million barrels in the Seven Rivers interval for a total OOIP of approximately 956 million barrels of oil. Our primary production is currently from the Seven Rivers zone. In addition to proven reserves, the Company believes it may access an additional 34 million barrels of oil by adding perforations in the Grayburg and San Andres formations, plus another 40 million barrels from the horizontal drilling program in the San Andres. With proven oil reserves of over 15 million barrels, combined with the potential 74 million additional barrels from the Grayburg and San Andres zones, LHO should produce oil and a revenue stream for more than two decades with a low decline rate. About the South Justis Field Property The South Justis Field ('SJF') is a carbonate reservoir, similar to the rest of the Permian. The SJF was first developed in the 1960's and had an initial production in the 6,000 BOPD range. The waterflood implemented at a cost of $40 million dollars in the 1990's by a major oil company had mediocre performance due to poor connectivity between wells, which indicates an opportunity for horizontal infill well drilling. The subsequent owners of the SJF had higher priorities, which led to an increase in idle wells with downhole failures, thus allowing the production to drop dramatically. The Seller acquired the field and has reactivated several wells with good results increasing the production of oil. This indicates that there are a significant number of wells that can be reactivated to increase production on existing wells. The SJF comprises of 5,360 contiguous acres with 208 combined producing and injection wells with well spacing of 50 acres. The field is located in the Central Basin of the prolific Permian Basin in Lea County, New Mexico located approximately 100 miles from EON's Grayburg-Jackson Oil Field property. The producing formations include the Glorietta, Blinebry, Tubb, Drinkard and Fusselman intervals that range from 5,000 feet to 7,000 feet in depth. The original-oil-in-place ('OOIP') is approximately 207 million barrels of oil. Forward-Looking Statements This press release includes 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to differ materially from what is expected. Words such as 'expects,' 'believes,' 'anticipates,' 'intends,' 'estimates,' 'seeks,' 'may,' 'might,' 'plan,' 'possible,' 'should' and variations and similar words and expressions are intended to identify such forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Such forward-looking statements relate to future events or future results, based on currently available information and reflect the Company's management's current beliefs. A number of factors could cause actual events or results to differ materially from the events and results discussed in the forward-looking statements. Important factors - including the availability of funds, the results of financing efforts and the risks relating to our business - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on EDGAR (see and with the Securities and Exchange Commission (see Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Investor Relations Michael J. Porter, President PORTER, LEVAY & ROSE, INC. [email protected] SOURCE: EON Resources Inc. press release

Discounted Shows For A Year: The Chase Card For Concertgoers
Discounted Shows For A Year: The Chase Card For Concertgoers

Forbes

time21 hours ago

  • Forbes

Discounted Shows For A Year: The Chase Card For Concertgoers

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Though concert ticket prices have been slowly declining, Chase Sapphire Reserve® cardholders can score multiple free shows each year. The card offers two statement credits annually for Stubhub and Viagogo purchases, making it the ideal choice to use for booking your next night at the theater, arena tour concert or comedy show. The Chase Sapphire Reserve® underwent a summer glow-up, with Chase adding a plethora of new benefits—including a $300 annual StubHub and Viagogo credit. While this an ideal perk for a live music, StubHub and Viagogo's ticket offerings don't stop at concerts. The platforms cover all kinds of live entertainment offerings, including sports games, theater productions and comedy shows. With the revamp comes the upping of the card's annual fee, from $550 to $795. While this does place the card among the pricier options in the market, Chase has been hard at work packing in new benefits to make the updated fee worthwhile. Cardholders can activate the $300 StubHub and Viagogo credit through the Chase website or mobile app. The credit is split into two $150 statement credits, with the first available to use between January 1 and June 30 and the other between July 1 and December 31. After making a qualifying purchase on StubHub or Viagogo using their Chase Sapphire Reserve card, the statement credit is automatically applied to the cardholder's account. The $300 credit also renews each year through December 31, 2027. Earn 100,000 bonus points + $500 Chase Travel℠ promo credit after you spend $5,000 on purchases in the first 3 months from account opening. Credit Score ranges are based on FICO® credit scoring. This is just one scoring method and a credit card issuer may use another method when considering your application. These are provided as guidelines only and approval is not guaranteed. In 2024, the average price of a concert ticket sat around $136, according to Pollstar. On ticket resale platforms like StubHub and Viagogo, ticket prices aren't set and may rise or fall depending on the demand for the show, timing and sometimes luck. Scalpers often list tickets on resale sites for exorbitant prices soon after a show announcement to capitalize off buyer panic. Waiting to purchase a resale ticket until the show inches closer might save you money, depending on if demand for it isn't staunch. How each cardholder decides to spend their $300 annual credit is up to them, but with strategic timing, the credit can stretch further and cover more shows. To sweeten the deal, new Sapphire Reserve cardholders can also earn an elevated welcome offer of 100,000 bonus points, plus a $500 Chase Travel℠ promo credit after spending $5,000 on purchases in the first three months from account opening. The offer on this page ends at 9 a.m. ET on August 21, 2025. For those who want to turn their show ticket spending into rewards for a getaway, the Chase Ultimate Rewards® points from this offer can help cover a flight or hotel booking. Or if you're still concert-crazy, these points can also be redeemed for cash back, perfect for building out your budget for the next presale. The Reserve's high annual fee might be a dealbreaker for some, but for frequent travelers and concertgoers, it can be a no-brainer. However, consumers should scour through the card's perks to determine if it provides enough value for its cost before applying.

Cybin Announces Results of Annual Meeting of Shareholders
Cybin Announces Results of Annual Meeting of Shareholders

Business Wire

timea day ago

  • Business Wire

Cybin Announces Results of Annual Meeting of Shareholders

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) (' Cybin ' or the ' Company '), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce the voting results for each of the matters presented at the Company's annual meeting of shareholders held on August 18, 2025 (the ' Meeting '). There were 90 shareholders represented in person or by proxy at the Meeting holding 11,264,212 common shares, representing 48.92% of Cybin's total issued and outstanding common shares as at the record date for the Meeting. The voting results for each matter presented at the Meeting are set out below: 1. Appointment of Auditor Zeifmans LLP was appointed auditor of Cybin until the next annual meeting of shareholders at renumeration to be fixed by the directors of Cybin. Voting results are set out below: 2. Number of Directors The special resolution to set the number of directors of Cybin at six was approved by at least two-thirds of the votes casts by the shareholders who voted in respect of the resolution present or represented by proxy at the Meeting. Voting results are set out below: 3. Election of Directors Each of the nominees for election as director listed in Cybin's management information circular dated July 14, 2025 were elected as directors of Cybin for the ensuing year or until their successors are elected or appointed. Voting results are set out below: George Tziras did not stand for re-election as a director. The Company thanks Mr. Tziras for his past service. About Cybin Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet need for people who suffer from mental health conditions. With promising proof-of-concept data, Cybin is working to change the mental health treatment landscape through the introduction of intermittent treatments that provide long lasting results. The Company is currently developing CYB003, a proprietary deuterated psilocin analog, in Phase 3 studies for the adjunctive treatment of major depressive disorder and CYB004, a proprietary deuterated N, N-dimethyltryptamine molecule in a Phase 2 study for generalized anxiety disorder. The Company also has a research pipeline of investigational, 5-HT-receptor focused compounds. Founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For Company updates and to learn more about Cybin, visit or follow the team on X, LinkedIn, YouTube and Instagram. Cautionary Notes and Forward-Looking Statements Certain statements in this news release relating to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as 'may', 'should', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe' or 'continue', or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the Company's plans to engineer proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health conditions. Any forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the psychedelics market; the ability of the Company to successfully achieve its business objectives; plans for growth; political, social and environmental uncertainties; employee relations; the presence of laws and regulations that may impose restrictions in the markets where the Company operates; implications of disease outbreaks on the Company's operations; and the risk factors set out in each of the Company's management's discussion and analysis for the year ended March 31, 2025 and the Company's annual information form for the year ended March 31, 2025, which are available under the Company's profile on SEDAR+ at and with the U.S. Securities and Exchange Commission on EDGAR at Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Cybin makes no medical, treatment or health benefit claims about Cybin's proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds. The efficacy of such products has not been confirmed by approved research. There is no assurance that the use of psilocin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds can diagnose, treat, cure or prevent any disease or condition. Rigorous scientific research and clinical trials are needed. If Cybin cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on Cybin's performance and operations.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store